Gastric cancer is an aggressive solid-tumor malignancy with poor prognosis. The
epidemiologic face of gastric cancer is changing and further insight into its heterogenous …

Gastric cancer is among the most prevalent and deadliest of cancers globally. To derive
mechanistic insight into the pathways governing this disease, we generated a Claudin18 …

Matrix metalloproteinase-12 (MMP12), or macrophage metalloelastase, plays important
roles in extracellular matrix (ECM) component degradation. Recent reports show MMP12 …

Background: Recent epidemiologic studies have found that patients with diabetes have a
higher risk of gastric cancer (GC), and the long-term use of metformin is associated with a …

Background Gastric cancer (GC) is the third leading cause of cancer death. Early detection
is a key factor to reduce its mortality. Methods We retrospectively collected pre-and …

Ovarian cancer is the most lethal gynecological tumor, and the 5‑year survival rate is only~
40%. The poor survival rate is due to cancer diagnosis at an advanced stage, when the …

Breast cancer is the most common cancer among women globally. In India, the incidence of
breast cancer has increased significantly during the last two decades with a higher …

Gastric cancer is the fifth most common malignancy but the third leading cause of cancer-
associated mortality worldwide. Therapy for gastric cancer remain largely suboptimal …

Background Pancreatic cancer is one of the most lethal tumors with poor prognosis, and
lacks of effective biomarkers in diagnosis and treatment. The aim of this investigation was to …

Genomic features have been gradually regarded as part of the fundamentals to the clinical
diagnosis and treatment for gastric cancer. However, the molecular alterations taking place …